Study suggests targeting amyloid beta production could be promising in AD
The neurodegenerative disease is currently the most common cause of dementia
Read Moreby Jen Brogan | Jul 24, 2024 | News | 0
The neurodegenerative disease is currently the most common cause of dementia
Read Moreby Jen Brogan | Jul 10, 2024 | News | 0
Around one in five dementia hospitalisations are due to potentially preventable causes
Read Moreby Jen Brogan | Jun 26, 2024 | News | 0
AD is the most common form of dementia, which affects over 944,000 people in the UK
Read Moreby Jen Brogan | Jun 24, 2024 | News | 0
The manifesto calls on the next UK government to make dementia a key health priority
Read Moreby Jen Brogan | Mar 19, 2024 | News | 0
The SOL3D pipeline addresses research challenges in relation to equipment, expertise and cost
Read Moreby Jen Brogan | Nov 20, 2023 | News | 0
The centre will help discover new treatments to prevent, halt and cure the condition
Read Moreby Jen Brogan | Nov 16, 2023 | News | 0
The funding will be used to develop new diagnostic tests, treatments and devices
Read Moreby Jen Brogan | Oct 20, 2023 | News | 0
The new technology was safely trialled on 20 healthy volunteers for the first time ever
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479